Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Pancreatic ductal adenocarcinoma (PDAC) is an extraordinarily lethal disease, which, despite a more or less efficient chemotherapeutic treatment, systematically displays a rapid and uncontrolled progression towards a fatal recurrence. Determining which cells give rise to such tumor recurrence is thu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoscience
Egile Nagusiak: Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Perspective
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://ncbi.nlm.nih.gov/pubmed/26244163
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak